UBS Group’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-23,781
| Closed | -$16K | – | 7428 |
|
|
2017
Q4 | $16K | Sell |
23,781
-6,673
| -22% | -$4.49K | ﹤0.01% | 5779 |
|
|
2017
Q3 | $10K | Buy |
30,454
+30,354
| +30,354% | +$9.97K | ﹤0.01% | 6012 |
|
|
2017
Q2 | $0 | Sell |
100
-1,209
| -92% | – | ﹤0.01% | 7270 |
|
|
2017
Q1 | $1K | Buy |
1,309
+1,159
| +773% | +$885 | ﹤0.01% | 6642 |
|
|
2016
Q4 | $0 | Sell |
150
-3,531
| -96% | – | ﹤0.01% | 7338 |
|
|
2016
Q3 | $7K | Buy |
3,681
+3,597
| +4,282% | +$6.84K | ﹤0.01% | 6109 |
|
|
2016
Q2 | $0 | Sell |
84
-4,311
| -98% | – | ﹤0.01% | 7315 |
|
|
2016
Q1 | $4K | Buy |
4,395
+1,163
| +36% | +$1.06K | ﹤0.01% | 6292 |
|
|
2015
Q4 | $4K | Buy |
3,232
+2,980
| +1,183% | +$3.69K | ﹤0.01% | 6455 |
|
|
2015
Q3 | $2K | Hold |
252
| – | – | ﹤0.01% | 6665 |
|
|
2015
Q2 | $2K | Sell |
252
-1,927
| -88% | -$15.3K | ﹤0.01% | 6625 |
|
|
2015
Q1 | $19K | Sell |
2,179
-3,360
| -61% | -$29.3K | ﹤0.01% | 5441 |
|
|
2014
Q4 | $55K | Buy |
+5,539
| New | +$55K | ﹤0.01% | 4658 |
|